Mobile

A randomized, double blind, placebo controlled, multicenter study to determine the effect of QVA149 on mean 24-hours heart rate in patients with Chronic Obstructive Pulmonary Disease (COPD)

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-003670-25

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the effect of 14 days treatment with QVA149 600µg/100µg, QVA149 300µg/100µg, QVA149 150µg/100µg on change in mean 24-h heart rate (ventricular rate) compared to placebo delivered by the Single Dose Dry Powder Inhaler (SDDPI) Concept 1 once a day in patients with moderate to severe stable Chronic Obstructive Pulmonary Disease (COPD).

Critère d'inclusion

  • Chronic Obstructive Pulmonary Disease

Liens